PTKMF (PT Kimia Farma Tbk) Debt-to-Equity : 1.38 (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is PT Kimia Farma Tbk Debt-to-Equity?

PT Kimia Farma Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $416.07 Mil. PT Kimia Farma Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $75.93 Mil. PT Kimia Farma Tbk's Total Stockholders Equity for the quarter that ended in Jun. 2024 was $357.66 Mil. PT Kimia Farma Tbk's debt to equity for the quarter that ended in Jun. 2024 was 1.38.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for PT Kimia Farma Tbk's Debt-to-Equity or its related term are showing as below:

PTKMF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.14 Med: 1.07 Max: 3.04
Current: 1.38

During the past 13 years, the highest Debt-to-Equity Ratio of PT Kimia Farma Tbk was 3.04. The lowest was 0.14. And the median was 1.07.

PTKMF's Debt-to-Equity is ranked worse than
86.05% of 86 companies
in the Medical Distribution industry
Industry Median: 0.31 vs PTKMF: 1.38

PT Kimia Farma Tbk Debt-to-Equity Historical Data

The historical data trend for PT Kimia Farma Tbk's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Debt-to-Equity Chart

PT Kimia Farma Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.15

1.11

1.39

1.41

1.71

PT Kimia Farma Tbk Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Equity	Get a 7-Day Free Trial															1.01	0.99	1.71	1.32	1.38

Competitive Comparison of PT Kimia Farma Tbk's Debt-to-Equity

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Kimia Farma Tbk's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Debt-to-Equity falls into.

PT Kimia Farma Tbk Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

PT Kimia Farma Tbk's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(450.057	+	49.49)	/	292.363
	=	1.71

PT Kimia Farma Tbk's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(416.07	+	75.929)	/	357.664
	=	1.38

PT Kimia Farma Tbk (GREY:PTKMF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

PT Kimia Farma Tbk Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kimia Farma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (GREY:PTKMF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

KAEF:Indonesia

Address

Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110

Website

https://www.kimiafarma.co.id

PT Kimia Farma Tbk is an Indonesia based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in three categories including Ethical, Generic and others. Some of its product offerings include Topgesic, Protofen, Neurodial, Omeprazole, Antalgin, Pethidine, Salicylfresh and Doveri. It generates maximum revenue from the retail segment.

PT Kimia Farma Tbk Headlines

No Headlines